CompletedNCT00952874

Molecular Biology of Anal Cancer in HIV-Positive Patients

Studying Squamous cell carcinoma of the rectum

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: University Hospital, Geneva
Principal Investigator: Bernard Hirschel
Swidd HIV cohort
Enrollment: 30 target
Eligibility: 20-80 years · All sexes
Timeline: 2009 – 2010

Study locations (1)

University Hospital Geneva, Geneva, Switzerland

Collaborators

University of Lausanne Hospitals · University of Zurich

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00952874 on ClinicalTrials.gov

Other trials for Squamous cell carcinoma of the rectum

Additional recruiting or active studies for the same condition.

RECRUITINGPHASE2NCT06364384
Radical Concurrent Chemoradiotherapy With DDP/5-FU and PD-1 Antibody for Non-metastatic Rectal Squamous Cell Carcinoma
Sixth Affiliated Hospital, Sun Yat-sen University

See all trials for Squamous cell carcinoma of the rectum →

← Back to all trials